For research use only. Not for therapeutic Use.
1-Naphthohydroxamic acid (Cat No.:I016974) is a potent and selective HDAC8 inhibitor with IC50 of 14μM. The selectivity of 1-Naphthohydroxamic acid for HDAC8 is higher than class I HDAC1 and II class HDAC6 (IC50>100μM). 1-Naphthohydroxamic acid does not increase overall histone H4 acetylation, nor does it decrease total intracellular HDAC activity. 1-Naphthohydroxamic acid induces tubulin acetylation.
Catalog Number | I016974 |
CAS Number | 6953-61-3 |
Molecular Formula | C₁₁H₉NO₂ |
Purity | ≥95% |
Target | Epigenetics |
Storage | 2-8°C |
IUPAC Name | N-hydroxynaphthalene-1-carboxamide |
InChI | InChI=1S/C11H9NO2/c13-11(12-14)10-7-3-5-8-4-1-2-6-9(8)10/h1-7,14H,(H,12,13) |
InChIKey | JRZGPWOEHDOVMC-UHFFFAOYSA-N |
SMILES | C1=CC=C2C(=C1)C=CC=C2C(=O)NO |
Reference | [1]. Krennhrubec K, et al. Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors. Bioorg Med Chem Lett. 2007 May 15;17(10):2874-8.<br>[2]. Oehme I, et al. Histone deacetylase 8 in neuroblastoma tumorigenesis. Clin Cancer Res. 2009 Jan 1;15(1):91-9. |